Immunogenicity results of different vaccination schemes at different time points. حسب Rima Moghnieh (679199)

الموضوعات:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against laboratory-confirmed infections during the different waves. حسب Rima Moghnieh (679199)

الموضوعات:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against acute-care hospitalization attributed to laboratory-confirmed infections during the differen... حسب Rima Moghnieh (679199)

الموضوعات:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. حسب Rima Moghnieh (679199)

الموضوعات:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.4/BA.5 variant wave. حسب Rima Moghnieh (679199)

الموضوعات:

Humoral immune responses to SARS-CoV-2 spike protein following various primary vaccination schemes and booster doses with Sinopharm or Pfizer vaccines among COVID-19-naïve particip... حسب Rima Moghnieh (679199)

الموضوعات:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. حسب Rima Moghnieh (679199)

الموضوعات:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. حسب Rima Moghnieh (679199)

الموضوعات:

Fig 4 - حسب Rima Moghnieh (679199)

الموضوعات:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. حسب Rima Moghnieh (679199)

الموضوعات:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the mixed Delta and Omicron variant wave. حسب Rima Moghnieh (679199)

الموضوعات:

COVID-19 in Lebanon: The daily number of COVID-19 cases throughout the waves of the pandemic in Lebanon and associated SARS-CoV-2 variants between January 2021 and September 2022. حسب Rima Moghnieh (679199)

الموضوعات:

Study profile. حسب Rima Moghnieh (679199)

الموضوعات:

Fig 3 - حسب Rima Moghnieh (679199)

الموضوعات:

ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls. حسب Ananya Datta (19932144)

The (A) logistic regression model (LRM) and (B) random forest model (RFM) with only conservation scores as independent variables (orange, yellow) show decreased model fitting metri... حسب Bushra Haque (20513785)

EF-24 treatment significantly reduces cell viability in leukemia cell lines. حسب Ajeet P. Singh (22298432)

الموضوعات:

Histological scoring system of burned dermis. حسب Omid Mehrpour (9385929)

الموضوعات:

Histological scoring system of burned epidermis. حسب Omid Mehrpour (9385929)

الموضوعات:

Results of redundancy analysis. حسب Bianhua Zhang (22430652)

الموضوعات: "…aggregation coefficient decreased…"